Mirabegron: new treatment for OAB with fewer side-effects

Mirabegron (Betmiga) is a new class of drug for the treatment of overactive bladder. In our New products review, Steve Chaplin presents the clinical data relating to its efficacy and adverse events, and Professor Chapple discusses its place in treatment compared with anticholinergics.

Mirabegron new treatment for OAB with fewer side effects

Add yours ↓
Web design and marketing agency Leamington Spa